Psoriatic arthritis. Treatment outcome parameters

Psoriatic arthritis (PsA) has increasingly attracted the attention of clinical research in recent years with regard to long-term clinical registries, studies on epidemiology, genetics, and therapy. However, the methodology for assessing disease activity, damage and progression, as well as the result...

Full description

Saved in:
Bibliographic Details
Published in:Zeitschrift für Rheumatologie 2009-02, Vol.68 (1), p.16-22
Main Authors: Märker-Hermann, E, Behrens, F
Format: Article
Language:ger
Subjects:
Arthritis, Psoriatic - diagnosis
Arthritis, Psoriatic - therapy
Germany
Health Status Indicators
Humans
Outcome Assessment (Health Care) - methods
Rheumatology - methods
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Psoriatic arthritis (PsA) has increasingly attracted the attention of clinical research in recent years with regard to long-term clinical registries, studies on epidemiology, genetics, and therapy. However, the methodology for assessing disease activity, damage and progression, as well as the resulting definition of treatment outcome parameters have progressed far less in PsA as compared to other rheumatic diseases such as rheumatoid arthritis (RA). Most of the assessment methodologies have been adapted from clinical trials on RA, ankylosing spondylitis, or psoriasis, but have not yet been validated for use in PsA. This article gives an overview of general rheumatological and PsA-specific assessment methods and outcome parameters of PsA therapy.
ISSN:1435-1250
DOI:10.1007/s00393-008-0360-z